Profile data is unavailable for this security.
About the company
Kyowa Kirin Co., Ltd., formerly Kyowa Hakko Kirin Co., Ltd. is a Japan-based company principally engaged in the manufacture and sale of medical drugs. The Company operates through two business segments. Pharmaceuticals segment conducts research, development, manufacture and sale of pharmaceuticals and other products. Bio-chemicals segment is involved in the research, development, manufacture and sale of pharmaceuticals and industrial raw materials mainly for amino acid and nucleic acid related substances, as well as healthcare products.
- Revenue in JPY (TTM)312.22bn
- Net income in JPY46.82bn
- Incorporated1949
- Employees5.27k
- LocationKyowa Kirin Co LtdOtemachi Financial City Grand Cube1-9-2, Ote-machiCHIYODA-KU 100-0004JapanJPN
- Phone+81 352057200
- Fax+81 352057182
- Websitehttps://www.kyowakirin.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TAKARA BIO INC. | 32.85bn | 2.63bn | 345.11bn | 1.49k | 131.12 | 5.27 | 55.67 | 10.50 | 21.86 | 21.86 | 272.83 | 543.82 | 0.4532 | 1.67 | 5.02 | 22,123,230.00 | 3.65 | 3.64 | 3.96 | 3.99 | 60.55 | 57.92 | 8.05 | 7.75 | 5.02 | -- | 0.00 | 24.35 | -3.56 | 5.89 | 4.43 | 31.72 | -3.69 | 39.77 |
| JCR Pharmaceuticals Co Ltd | 24.81bn | 3.08bn | 388.09bn | 667.00 | 127.95 | 11.30 | 84.40 | 15.64 | 93.56 | 93.56 | 799.73 | 1,059.53 | 0.5060 | 0.8131 | 3.59 | 37,191,900.00 | 6.28 | 6.77 | 8.76 | 8.26 | 68.45 | 67.16 | 12.42 | 12.60 | 1.30 | -- | 0.3462 | 31.37 | 7.00 | 8.01 | -27.91 | 9.74 | 29.27 | 11.58 |
| ROHTO PHARMACEUTICAL CO., LTD. | 185.06bn | 15.13bn | 419.22bn | 6.62k | 26.84 | 2.92 | 19.15 | 2.27 | 132.27 | 132.27 | 1,617.74 | 1,215.11 | 0.9232 | 2.26 | 4.78 | 27,958,600.00 | 7.49 | 5.60 | 10.33 | 8.13 | 60.56 | 59.62 | 8.11 | 6.19 | 1.64 | -- | 0.0523 | 24.23 | 2.58 | 4.41 | 57.26 | 12.29 | 9.18 | 6.47 |
| Hisamitsu Pharmaceutical Co Inc | 136.64bn | 16.89bn | 458.19bn | 2.75k | 26.14 | 1.77 | 21.57 | 3.35 | 205.84 | 205.84 | 1,666.30 | 3,040.54 | 0.4654 | 2.98 | 3.84 | 49,778,140.00 | 5.80 | 6.60 | 6.52 | 7.57 | 61.83 | 62.83 | 12.46 | 12.97 | 5.72 | -- | 0.0062 | 36.07 | -1.68 | -2.10 | -2.66 | -0.096 | -5.22 | 0.739 |
| Medipal Holdings Corp | 3.24tn | 37.00bn | 525.24bn | 13.60k | 13.13 | 0.8803 | 8.07 | 0.1623 | 163.54 | 163.54 | 14,325.73 | 2,440.17 | 1.96 | 19.98 | 4.60 | 237,981,800.00 | 3.05 | 2.73 | 8.45 | 7.93 | 7.22 | 7.23 | 1.55 | 1.36 | 1.06 | -- | 0.0618 | 22.81 | 2.24 | 2.52 | 10.50 | 9.90 | 12.52 | 11.30 |
| Peptidream Inc | 4.15bn | 401.90m | 542.04bn | 107.00 | 1,679.45 | 30.73 | 572.86 | 130.77 | 2.56 | 2.56 | 32.52 | 140.10 | 0.2083 | 4.47 | 1.80 | 38,738,950.00 | 2.02 | -- | 2.27 | -- | 62.69 | -- | 9.70 | -- | 4.63 | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Sumitomo Dainippon Pharma Co Ltd | 499.11bn | 52.31bn | 545.52bn | 6.46k | 10.41 | 1.01 | 8.76 | 1.09 | 131.66 | 131.66 | 1,256.26 | 1,361.80 | 0.4883 | 1.89 | 3.87 | 77,296,740.00 | 4.38 | 4.72 | 7.01 | 6.66 | 72.61 | 75.05 | 8.97 | 8.74 | 0.5755 | -- | 0.3182 | 24.38 | 5.11 | 5.39 | -16.19 | 21.41 | 1.54 | 9.24 |
| Alfresa Holdings Corporation | 2.67tn | 38.10bn | 555.58bn | 12.07k | 13.14 | 1.04 | 11.14 | 0.208 | 179.97 | 179.97 | 12,620.84 | 2,273.80 | 1.96 | 16.53 | 4.32 | 221,259,600.00 | 2.80 | 2.85 | 7.68 | 8.10 | 7.53 | 7.51 | 1.43 | 1.41 | 1.04 | -- | 0.0023 | 24.09 | 2.20 | 2.19 | -3.48 | 11.93 | 5.31 | 10.94 |
| Nippon Shinyaku Co., Ltd. | 117.16bn | 17.75bn | 597.84bn | 2.03k | 32.29 | 3.83 | 28.10 | 5.10 | 263.54 | 263.54 | 1,739.48 | 2,219.45 | 0.6746 | 2.06 | 2.67 | 57,827,740.00 | 10.23 | 8.42 | 11.96 | 9.96 | 55.04 | 53.49 | 15.17 | 12.46 | 3.73 | -- | 0.00 | 29.79 | 1.67 | 7.83 | 3.46 | 23.45 | 7.51 | 28.03 |
| Santen Pharmaceutical Co Ltd | 239.98bn | 23.41bn | 838.72bn | 4.11k | 35.84 | 2.74 | 22.06 | 3.49 | 58.48 | 58.48 | 599.52 | 766.36 | 0.603 | 2.64 | 2.92 | 58,418,210.00 | 5.39 | 8.86 | 6.31 | 10.69 | 60.23 | 61.66 | 8.94 | 14.98 | 2.73 | 37.74 | 0.133 | 31.84 | 3.22 | 8.34 | -26.09 | -0.3469 | -32.62 | 4.18 |
| Kyowa Kirin Co Ltd | 312.22bn | 46.82bn | 1.56tn | 5.27k | 33.15 | 2.26 | 24.05 | 4.99 | 87.12 | 87.12 | 580.94 | 1,276.89 | 0.4063 | 1.81 | 3.47 | 59,279,100.00 | 6.09 | 5.27 | 6.75 | 5.96 | 73.75 | 66.26 | 15.00 | 11.57 | 5.13 | -- | 0.0259 | 44.13 | 12.64 | -1.71 | -23.47 | 18.83 | -9.31 | 10.93 |
| ONO PHARMACEUTICAL CO., LTD. | 293.35bn | 64.87bn | 1.76tn | 3.56k | 25.70 | 2.85 | 22.07 | 6.00 | 129.57 | 129.57 | 585.91 | 1,168.73 | 0.4446 | 2.39 | 3.68 | 82,401,970.00 | 9.86 | 8.05 | 11.21 | 9.19 | 73.11 | 73.13 | 22.17 | 19.49 | 2.49 | -- | 0.0132 | 44.99 | 1.31 | 16.58 | 15.84 | 35.70 | -6.33 | 4.56 |
| Eisai Co., Ltd | 707.20bn | 124.52bn | 2.80tn | 11.00k | 21.71 | 3.98 | 17.56 | 3.95 | 434.37 | 434.37 | 2,467.02 | 2,367.37 | 0.6844 | 2.54 | 4.01 | 64,302,870.00 | 12.11 | 6.57 | 16.35 | 8.61 | 75.81 | 68.85 | 17.69 | 11.26 | 1.86 | -- | 0.1134 | 65.68 | 8.21 | 4.87 | 92.10 | 23.00 | 22.21 | 1.30 |
Data as of Sep 25 2020. Currency figures normalised to Kyowa Kirin Co Ltd's reporting currency: Japanese Yen JPY
14.61%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 31 Aug 2020 | 19.06m | 3.53% |
| Asset Management One Co., Ltd.as of 15 Apr 2020 | 14.77m | 2.74% |
| Nikko Asset Management Co., Ltd.as of 30 Jul 2020 | 8.19m | 1.52% |
| Daiwa Asset Management Co. Ltd.as of 31 Aug 2020 | 7.83m | 1.45% |
| The Vanguard Group, Inc.as of 31 Aug 2020 | 7.23m | 1.34% |
| Massachusetts Financial Services Co.as of 31 Jul 2020 | 6.09m | 1.13% |
| BlackRock Fund Advisorsas of 03 Sep 2020 | 4.40m | 0.82% |
| Norges Bank Investment Managementas of 31 Dec 2019 | 4.17m | 0.77% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 03 Sep 2020 | 3.85m | 0.71% |
| Sumitomo Mitsui DS Asset Management Co., Ltd.as of 18 Sep 2020 | 3.33m | 0.62% |
More ▼
Data from 31 Dec 2019 - 30 Jun 2020Source: FactSet Research Systems Inc.
